Empowered Funds
PRME icon

Empowered Funds’s Prime Medicine PRME Stock Holding History

Empowered Funds’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$150K Buy
+49,148
New +$163K ﹤0.01% 2345

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Empowered Funds's PRME Position: Q3 2026 in Review

Empowered Funds opened a new position in Prime Medicine (PRME) in Q3 2026: 49,148 shares worth $150K. The stake represents ﹤0.01% of the portfolio and ranks #2345 among its holdings.

125 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

  • Empowered Funds held 49,148 shares of Prime Medicine worth $150K as of Q3 2026.
  • Prime Medicine was a new Empowered Funds position in Q3 2026.
  • Prime Medicine made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2345 holding.
  • 125 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.